SynDiag

SynDiag is a Fem Tech and Med Tech startup founded in 2019, originating from the Polytechnic University of Turin, Italy. The company focuses on developing AI-based digital platforms to enhance the early diagnosis of gynecological cancers, particularly ovarian cancer. Its main product, OvAi, is an AI-powered software solution that integrates with ultrasound machines. This tool aids physicians in the early detection and interpretation of ultrasound images related to ovarian cancer. By utilizing clinical data from leading hospitals, OvAi aims to improve diagnostic accuracy and reduce false diagnoses. SynDiag also provides support for doctors during the diagnosis process, offers optimized follow-up plans for medical institutions, and enhances decision support for medical image interpretation in gynecology. Headquartered in Turin, Italy, SynDiag operates in the medical devices, biotech healthcare, and ICT for health sectors, with a commitment to advancing decision support and early diagnosis through artificial intelligence in medical imaging.

• Employees 9